Molecular Characteristics of Large Parathyroid Adenomas

[1]  N. Kumari,et al.  Primary hyperparathyroidism presenting as hypercalcemic crisis: Twenty-year experience , 2015, Indian journal of endocrinology and metabolism.

[2]  S. Bhadada,et al.  Changes in clinical & biochemical presentations of primary hyperparathyroidism in India over a period of 20 years , 2014, The Indian journal of medical research.

[3]  C. Larsson,et al.  Genetic characterization of large parathyroid adenomas , 2012, Endocrine-related cancer.

[4]  J. Connolly,et al.  Large parathyroid tumors have an increased risk of atypia and carcinoma. , 2011, American journal of surgery.

[5]  R. DeLellis,et al.  Parathyroid tumors and related disorders , 2011, Modern Pathology.

[6]  C. Lo,et al.  Endocrine surgery : principles and practice , 2011 .

[7]  C. Larsson,et al.  Parafibromin and APC as Screening Markers for Malignant Potential in Atypical Parathyroid Adenomas , 2010, Endocrine pathology.

[8]  S. Gupta,et al.  Hyperparathyroidism and Malnutrition with Severe Vitamin D Deficiency , 2009, World Journal of Surgery.

[9]  B. Teh,et al.  Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. , 2009, The Journal of clinical endocrinology and metabolism.

[10]  E. Chin,et al.  Correlation of Intraoperative Parathyroid Hormone Levels With Parathyroid Gland Size , 2007, The Laryngoscope.

[11]  Kristin Jensen,et al.  Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? , 2007, Cancer.

[12]  S. Nouraei,et al.  Primary hyperparathyroidism: do perioperative biochemical variables correlate with parathyroid adenoma weight or volume? , 2007, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[13]  A. Gill,et al.  Loss of Nuclear Expression of Parafibromin Distinguishes Parathyroid Carcinomas and Hyperparathyroidism-Jaw Tumor (HPT-JT) Syndrome-related Adenomas From Sporadic Parathyroid Adenomas and Hyperplasias , 2006, The American journal of surgical pathology.

[14]  N. Krishnani,et al.  Indian Primary Hyperparathyroidism Patients with Parathyroid Carcinoma do not Differ in Clinicoinvestigative Characteristics from Those with Benign Parathyroid Pathology , 2006, World Journal of Surgery.

[15]  M. Papotti,et al.  Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases. , 2005, Human pathology.

[16]  Ximing J. Yang,et al.  Loss of Parafibromin Immunoreactivity Is a Distinguishing Feature of Parathyroid Carcinoma , 2004, Clinical Cancer Research.

[17]  T Takano,et al.  PGP9.5 mRNA could contribute to the molecular-based diagnosis of medullary thyroid carcinoma. , 2004, European journal of cancer.

[18]  C. Marcocci,et al.  A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer , 2004, Clinical endocrinology.

[19]  K. Sandelin,et al.  Clinical course of metastatic parathyroid cancer , 1994, World Journal of Surgery.

[20]  J. Carpten,et al.  Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. , 2003, The New England journal of medicine.

[21]  K Hammje,et al.  HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours , 2003, Journal of medical genetics.

[22]  J. Carpten,et al.  HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome , 2002, Nature Genetics.

[23]  S. Asa,et al.  Correlation of biochemical parameters with single parathyroid adenoma weight and volume , 2002, Head & neck.

[24]  A. Nakao,et al.  PGP9.5 as a marker for invasive colorectal cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  J. Rastad,et al.  Unique clinical characteristics of primary hyperparathyroidism in India , 2001, The British journal of surgery.

[26]  E. Shane,et al.  CHAPTER 33 – Parathyroid Carcinoma , 2001 .

[27]  A. Nakao,et al.  PGP9.5 as a prognostic factor in pancreatic cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  S. Mishra,et al.  Advanced skeletal manifestations in primary hyperparathyroidism. , 1998, Canadian journal of surgery. Journal canadien de chirurgie.

[29]  P. Wollan,et al.  Immunohistochemical analysis of the cell cycle-associated antigens Ki-67 and retinoblastoma protein in parathyroid carcinomas and adenomas , 1995, Endocrine pathology.

[30]  D. Louis,et al.  p53 abnormalities in human parathyroid carcinoma. , 1994, The Journal of clinical endocrinology and metabolism.

[31]  K. Sandelin,et al.  Histopathological Variables and DNA Cytometry in Parathyroid Carcinoma , 1993, The American journal of surgical pathology.